Sarah Cevallos Named Chief Revenue Cycle Officer for Florida Cancer Specialists & Research Institute
- Amanda Bridges
- December 23, 2015
- News
Cevallos to Assume Greater Leadership Role for
Nation’s Largest Independent Hematology/Oncology Practice
Fort Myers, FL – December 21, 2015 . . . Florida Cancer Specialists & Research Institute (FCS), the leading community oncology/hematology practice in the state, is pleased to announce that Sarah Cevallos has been named Chief Revenue Cycle Officer and is assuming a broad range of responsibilities in overseeing Revenue Cycle for the organization.
FCS CEO Brad Prechtl said, “Sarah has consistently demonstrated leadership qualities that have earned the respect of her peers and the employees in the departments she oversees. Over the past seven years at FCS, she has developed a strong track record for achieving strategic improvements within her areas of responsibility. We rely on leaders like Sarah to contribute to our success.”
As Chief Revenue Cycle Officer, Sarah Cevallos is responsible for providing strategic leadership and direction to all Revenue Cycle responsibilities for the Florida Cancer Specialists’ physician network. In this role, she supports FCS through excellence in patient financial services, billing, timely collection, and precise payment posting, while delivering a positive patient experience. Sarah is also responsible for developing our payer partnerships. Since joining FCS, she has held several finance-related positions of increasing responsibility. Sarah holds a Bachelor of Science degree in Business Management from Nova Southeastern University and an MBA from Western Governors University with a concentration in Healthcare Management. In addition to her work with FCS, Sarah serves as Clinical Practice Committee Member for the Florida Association of Clinical Oncology (FLASCO).
Ms. Cevallos said, “FCS’ Revenue Cycle team has impressed me from the day I began my career here in 2008. I am honored to be part of this exceptional group of thoughtful individuals that works tirelessly to ensure that our patients, physicians and payer partners continue to have the confidence in our organization to treat, and more importantly, beat these difficult diseases that we fight every day. I am energized by this new opportunity, and I look forward to our continued success.”
Florida Cancer Specialists & Research Institute offers a full range of oncology and hematology services, including clinical research and the use of evidence-based medicine and proactive patient support services. FCS is a strategic site of the Sarah Cannon Research Institute, one of the largest community-based clinical trial organizations in the United States.
